MPI8
MPI8 (TG0205221) is an inhibitor of the major protease of SARS-CoV-2 (MPro) with high antiviral activity. MPI8 exerts its antiviral effect by dual and selective inhibition of SARS-CoV-2 MPro and host cell cysteine protease L (cathepsin L). MPI8 can be used in clinical studies of COVID-19.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 856242-63-2
- 分子式: C32H48N4O7
- 分子量:600.75
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
Cathepsin アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
IC50 & Target
|
SARS-CoV‑2 Main Protease |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK-293T | CC50 |
70 μM
Compound: MPI8
|
Cytotoxicity against HEK293T cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against HEK293T cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 38608245] |
| Vero C1008 | CC50 |
>200 μM
Compound: 105
|
Cytotoxicity against African green monkey Vero E6 cells assessed as reduction of cell viability by CCK8 assay
Cytotoxicity against African green monkey Vero E6 cells assessed as reduction of cell viability by CCK8 assay
|
[PMID: 34798775] |
化学情報
-
CAS 番号 856242-63-2
-
分子量 600.75
-
分子式 C32H48N4O7
-
SMILES
O=C(N[C@H](C(N[C@H](C(N[C@H](C=O)C[C@H]1C(NCC1)=O)=O)CC2CCCCC2)=O)[C@@H](C)OC(C)(C)C)OCC3=CC=CC=C3
-
別名
TG0205221
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Ma X R, et al. MPI8 is potent against SARS‐CoV‐2 by inhibiting dually and selectively the SARS‐CoV‐2 main protease and the host cathepsin L[J]. ChemMedChem, 2022, 17(1): e202100456. [Content Brief]
[2]. Yang S, et al. Synthesis, crystal structure, structure− activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor[J]. Journal of medicinal chemistry, 2006, 49(16): 4971-4980. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
MPI8 関連分類
HY-158763 関連分類
Powered by Bioz